Bolt Biotherapeutics Correlations

BOLT Stock

USD 0.63 0.01 1.56%

The current 90-days correlation between Bolt Biotherapeutics and KBC Groep NV is 0.24 (i.e., Modest diversification). The correlation of Bolt Biotherapeutics is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak. If the correlation is 0, the equities are not correlated; they are entirely random.

Bolt Biotherapeutics Correlation With Market

Modest diversification

The correlation between Bolt Biotherapeutics and DJI is 0.21 (i.e., Modest diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Bolt Biotherapeutics and DJI in the same portfolio, assuming nothing else is changed.

Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Bolt Biotherapeutics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of economic analysis.

For more information on how to buy Bolt Stock please use our How to Invest in Bolt Biotherapeutics guide.

Moving together with Bolt Stock

0.66	VALN	Valneva SE ADR	Pair Corr
0.77	DYAI	Dyadic International	Pair Corr
0.77	ERNA	Eterna Therapeutics	Pair Corr
0.81	DNA	Ginkgo Bioworks Holdings	Pair Corr
0.7	PTN	Palatin Technologies	Pair Corr
0.93	INAB	In8bio Inc	Pair Corr
0.83	INKT	Mink Therapeutics	Pair Corr
0.75	MBIO	Mustang Bio	Pair Corr
0.79	MNMD	Mind Medicine	Pair Corr
0.83	MOLN	Molecular Partners	Pair Corr
0.85	NXTC	NextCure	Pair Corr
0.89	ONCT	Oncternal Therapeutics	Pair Corr
0.71	ABCL	Abcellera Biologics	Pair Corr
0.81	ABOS	Acumen Pharmaceuticals	Pair Corr

Moving against Bolt Stock

0.8	GILD	Gilead Sciences	Pair Corr
0.67	INBX	Inhibrx Symbol Change	Pair Corr
0.64	JNJ	Johnson Johnson Fiscal Year End 28th of January 2025	Pair Corr
0.61	BMY	Bristol Myers Squibb	Pair Corr
0.58	LLY	Eli Lilly	Pair Corr
0.54	GNFT	Genfit	Pair Corr
0.49	A	Agilent Technologies Fiscal Year End 18th of November 2024	Pair Corr
0.37	ZURA	Zura Bio Limited	Pair Corr
0.36	WVE	Wave Life Sciences	Pair Corr
0.34	SLS	Sellas Life Sciences	Pair Corr
0.87	SMMT	Summit Therapeutics PLC	Pair Corr
0.82	BNTX	BioNTech SE	Pair Corr
0.81	TARS	Tarsus Pharmaceuticals	Pair Corr
0.8	TELO	Telomir Pharmaceuticals,	Pair Corr
0.74	AMLX	Amylyx Pharmaceuticals	Pair Corr
0.73	TCBPW	TC BioPharm plc	Pair Corr
0.68	APGE	Apogee Therapeutics,	Pair Corr
0.62	ASMB	Assembly Biosciences	Pair Corr
0.61	ABBV	AbbVie Inc	Pair Corr
0.54	ANNX	Annexon	Pair Corr

Related Correlations Analysis

	KBCSY	PFE	JPM	DWLD	FRO	JBLU	MRK	JNJ	CVX	ALK
KBCSY		0.07	0.32	0.45	0.27	0.06	0.11	0.26	0.26	0.38	KBCSY
PFE	0.07		-0.16	-0.18	0.0	0.29	0.25	-0.05	0.39	0.12	PFE
JPM	0.32	-0.16		0.41	0.03	0.12	-0.12	0.32	0.23	0.28	JPM
DWLD	0.45	-0.18	0.41		0.31	0.7	-0.47	0.2	0.24	0.85	DWLD
FRO	0.27	0.0	0.03	0.31		0.11	-0.01	-0.5	0.52	0.04	FRO
JBLU	0.06	0.29	0.12	0.7	0.11		-0.31	0.01	0.42	0.81	JBLU
MRK	0.11	0.25	-0.12	-0.47	-0.01	-0.31		-0.27	0.3	-0.26	MRK
JNJ	0.26	-0.05	0.32	0.2	-0.5	0.01	-0.27		-0.53	0.27	JNJ
CVX	0.26	0.39	0.23	0.24	0.52	0.42	0.3	-0.53		0.21	CVX
ALK	0.38	0.12	0.28	0.85	0.04	0.81	-0.26	0.27	0.21		ALK
	KBCSY	PFE	JPM	DWLD	FRO	JBLU	MRK	JNJ	CVX	ALK

Click cells to compare fundamentals

Check Volatility

Backtest Portfolio

Please upgrade your account to get full access to Macroaxis premium features

Correlation Matchups

Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.

High positive correlations

ALK	+ 0.85	DWLD
ALK	+ 0.81	JBLU
JBLU	+ 0.7	DWLD
CVX	+ 0.52	FRO
DWLD	+ 0.45	KBCSY
CVX	+ 0.42	JBLU

High negative correlations

CVX	- 0.53	JNJ
JNJ	- 0.5	FRO
MRK	- 0.47	DWLD
MRK	- 0.31	JBLU
JNJ	- 0.27	MRK
ALK	- 0.26	MRK

Risk-Adjusted Indicators

There is a big difference between Bolt Stock performing well and Bolt Biotherapeutics Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Bolt Biotherapeutics' multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.

	Mean Deviation	Jensen Alpha	Sortino Ratio	Treynor Ratio	Semi Deviation	Expected Shortfall	Potential Upside	Value @Risk	Maximum Drawdown
KBCSY	1.06	(0.04)	(0.06)	(0.02)	1.59	(1.10)	1.92	(2.35)	7.81
PFE	0.98	(0.05)	(0.08)	(0.01)	1.17	(1.12)	2.73	(2.27)	6.28
JPM	1.00	0.01	0.02	0.09	1.53	(0.92)	2.06	(2.27)	7.98
DWLD	1.08	0.10	0.07	0.17	1.38	(1.09)	2.17	(2.17)	8.46
FRO	2.07	(0.14)	0.00	(0.02)	0.00	0.00	3.80	(4.85)	13.71
JBLU	3.09	0.36	0.09	0.25	4.23	(3.42)	7.53	(4.79)	32.97
MRK	0.99	(0.18)	0.00	2.46	0.00	0.00	1.68	(2.07)	11.82
JNJ	0.68	0.09	0.01	1.65	0.78	(0.70)	1.84	(1.42)	4.73
CVX	1.09	(0.18)	0.00	(0.09)	0.00	0.00	1.65	(2.62)	6.78
ALK	1.64	0.17	0.11	0.21	1.68	(1.82)	4.23	(3.17)	9.25

Bolt Biotherapeutics Corporate Management

Randall Schatzman	CEO Director	Profile
Edith MD	Chief Officer	Profile
Michael Alonso	Senior Research	Profile
MBA CFA	Chief Officer	Profile
Ming Yin	VP Biometrics	Profile
Bruce MD	Sr Medicine	Profile

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC